Primary Myelofibrosis
Differential Diagnosis
- Overview
- Cellular phase
- Essential thrombocythemia
- Higher bleeding risk in cellular phase MF than in ET
- Chronic myelogenous leukemia
- MDS with increased megakaryocytes (e.g. 5q- syndrome)
- Essential thrombocythemia
- Fibrotic phase
- Post polycythemia vera or essential thrombocythemia myelofibrosis
- CML with fibrosis
- AML or MDS with fibrosis
- Secondary marrow fibrosis
- Cellular phase
Common Myeloproliferative Neoplasms - Overview
| CML | PV | PMF | ET | |
|---|---|---|---|---|
| Tyrosine kinase | ABL | JAK2 | JAK2 or MPL | JAK2 or MPL |
| Blood | ↑WBC with IG, basophils | Normo or hypochromatic anemia, may have ↑platelets & basophils | Leukoerythroblastic with teardrops | ↑Platelets, often abnormal |
| Marrow | ↑↑Myeloids | Panmyelosis, ± erythroid hyperplasia, atypical megas | Panmyelosis, atypical megas | ↑↑Megas |
| Marrow fibrosis | Varies | ↑In spent phase | ↑↑In fibrotic phase | Minimal |
| Splenomegaly | ++ | ++ | +++ | ± |
| Clinical Presentation /Other | B symptoms | Hypertension, thrombosis, pruritus,↓EPO | B symptoms, bleeding, gout | Thrombosis, hemorrhage |
Essential Thrombocythemia vs Cellular Phase Primary Myelofibrosis vs CML
| Essential Thrombocythemia | Cellular Phase Primary Myelofibrosis | CML with p230 | |
|---|---|---|---|
| Cellularity | Normal to moderately hypercellular | Markedly hypercellular (cellular phase) | Markedly hypercellular |
| Megas - Distribution | Dispersed or loose clusters | Tight clusters, touching each other | Dispersed or loose clusters |
| Megas - Size | Large and giant | Pleomorphic | Variable, may have dwarf forms |
| Megas - Nuclei | Lobulated | Bulbous, hyperchromatic | Hypolobated |
| Megas - Cytoplasm | Mature | Variable, may have naked nuclei | Mature |
| Granulopoietic Hyperplasia | Infrequent, mild | Moderate to marked in cellular phase | Marked |
| Splenomegaly | Infrequent | Frequent | Rare |
| JAK2V617I | Allele burden <50% | Allele burden >50% |
Hematolymphoid Disorders with Marrow Fibrosis (overview)
| Disorder | Distinguishing Feature(s) |
|---|---|
| Polycythemia Vera, Fibrotic Phase | History of PV / JAK2+ |
| Essential Thrombocythemia, Fibrotic Phase (rare) | History of ET / may be JAK2+ |
| CML, Fibrotic Phase | History of CML / BCR-ABL1+ |
| MDS with Fibrosis | Dysplastic features in marrow |
| Acute Megakaryoblastic Leukemia | Blasts, acute onset |
| Osteosclerotic Myeloma | Plasma cells. light chain restricted |
| Acute Pan-myelosis with Myelofibrosis | Bone pain, acute onset |
| Primary Myelofibrosis | Clustered atypical megakaryocytic hyperplasia |
| Hairy cell leukemia | Clonal B cells |
- Infections
- Autoimmune diseases
- Chronic inflammatory conditions
- Hairy cell leukemia and other lymphoid neooplasms
- Metastatic malignancy
- Chronic toxic myelopathies

